Cost Effectiveness of Nintedanib Versus Pirfenidone Treatment In Idiopathic Pulmonary Fibrosis In Turkey

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.1493
https://www.valueinhealthjournal.com/article/S1098-3015(17)31827-2/fulltext
Title : Cost Effectiveness of Nintedanib Versus Pirfenidone Treatment In Idiopathic Pulmonary Fibrosis In Turkey
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31827-2&doi=10.1016/j.jval.2017.08.1493
First page : A646
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1343
Categories :
Tags :
Regions :
ViH Article Tags :